| 发明名称 |
THE USE OF GLATIRAMER ACETATE (COPOLYMER 1) IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS |
| 摘要 |
The present invention involves the administration of Copolymer 1 (glatiramer acetate) to treat inflammatory, non-autoimmune central nervous system (CNS) diseases, alleviate the symptoms thereof, inhibit the activity of matrix metalloproteinases and suppress cytokine production by T lymphocytes.
|
| 申请公布号 |
WO0193828(A1) |
申请公布日期 |
2001.12.13 |
| 申请号 |
WO2001US18248 |
申请日期 |
2001.06.05 |
| 申请人 |
TEVA PHARMACEUTICALS INDUSTRIES, LTD.;TEVA PHARMACEUTICALS USA, INC.;YONG, V., WEE;CHABOT, SOPHIE |
发明人 |
YONG, V., WEE;CHABOT, SOPHIE |
| 分类号 |
A61K9/02;A61K9/72;A61K31/785;A61K38/55;A61K45/00;A61P25/00;A61P25/16;A61P25/28;A61P27/06;A61P29/00;A61P31/04;A61P31/18;A61P35/00;A61P43/00;(IPC1-7):A61K9/00;A61F9/02;A61F13/00;A61K38/00 |
主分类号 |
A61K9/02 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
